← All tickers

Is ALT Worth Buying in 2026?

Altimmune, Inc. Common Stock

STOCK PHARMACEUTICAL PREPARATIONS Updated 2026-06-14

Here’s whether Altimmune, Inc. Common Stock (ALT) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bearish.

🔴
Bearish

Concerns: trading below the 200-day MA (long-term downtrend); below the 50-day MA (medium-term momentum negative); 50-day MA is falling (-2.86% over 10 days); weak 1-year return of -63.5%; 3-month momentum negative (-27.9%). Currently 66.2% off its 52-week high. Score: -6/7.

Ready to act on this? 📈 Trade on Webull

ALT is trading below its 200-day MA ($3.91) — a key warning sign the longer-term trend is under pressure. An RSI of 32.1 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of -63.5% compares to +22.9% for SPY (trailed the market by 86.4%). The current 66.2% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.

$10,000 invested 1 year ago → $3,650 today
vs. S&P 500 (SPY) — same period trailed market by 86.4%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

✗Above 200-day MA ($3.91)
✗Above 50-day MA ($3.02)
✓RSI(14) neutral zone (30–70) — currently 32.1
✗Positive return (-63.5%)
!Within 10% of period high (−66.2%)
Period Range $2.61
$2.56 $7.73
RSI (14) 32.1
0 · OversoldOverbought · 100

Key Metrics

Price$2.61
Period Return-63.5%
Period High$7.73
Period Low$2.56
Drawdown−66.2%
MA-50$3.02
MA-200$3.91
RSI (14)32.1
Avg Volume (30d)3.0M
vs. SPYtrailed by 86.4%
Return Rank#1135 of 1246

Trade ALT

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers